New from NICE

NICE recommends canagliflozin (Invokana), the second SGLT2 inhibitor introduced in the UK, as a component of dual or triple therapy and in combination with insulin to treat type 2 diabetes.

New from NICE

Add yours ↓
Web design and marketing agency Leamington Spa